Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
06/08/2011 | EP2330201A1 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
06/08/2011 | EP2330198A1 IL-1 related polypeptides |
06/08/2011 | EP2330197A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
06/08/2011 | EP2330196A2 Method for isolation of soluble polypeptides |
06/08/2011 | EP2330195A2 Method for isolation of soluble polypeptides |
06/08/2011 | EP2330193A1 Improved antibody molecule |
06/08/2011 | EP2330192A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
06/08/2011 | EP2330188A1 Circovirus sequences associated with porcine wasting disease (PWD) |
06/08/2011 | EP2330132A1 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
06/08/2011 | EP2330131A1 Antibodies against HER2 truncated variant CTF-611 |
06/08/2011 | EP2330130A1 Human monoclonal antibodies against CD20 |
06/08/2011 | EP2330129A2 Anti-TNF antibodies, compositions, methods and uses |
06/08/2011 | EP2330128A1 Modified anti-heparin/pf4 complex antibody and hit antibody standard |
06/08/2011 | EP2330123A2 HIV resistance genes |
06/08/2011 | EP2330121A2 Binding moieties based on Shark IgNAR domains |
06/08/2011 | EP2330120A2 Binding moieties based on Shark IgNAR domains |
06/08/2011 | EP2330118A1 Gene conferring resistance to Phytophthora infestans (late-blight) in solanaceae |
06/08/2011 | EP2330117A1 Genes of an otitis media isolate of nontypeable Haemophilus influenzae |
06/08/2011 | EP2330116A1 Replikin peptides and uses thereof |
06/08/2011 | EP2330115A1 Replikin peptides and uses thereof |
06/08/2011 | EP2330111A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases |
06/08/2011 | EP2329847A2 Use of an antibody or an immunotoxin that selectively binds to CD123 to impair hematologic cancer progenitor cells |
06/08/2011 | EP2329844A1 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use |
06/08/2011 | EP2329837A1 Promoting bone growth |
06/08/2011 | EP2329814A1 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer |
06/08/2011 | EP2329267A1 Mannose-6-phosphate-binding antibodies and their uses |
06/08/2011 | EP2328934A1 T-cell receptor antibodies and methods of use thereof |
06/08/2011 | EP2328933A1 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection |
06/08/2011 | EP2328932A1 Anti-cd5 antibodies |
06/08/2011 | EP2328931A1 Anti-hepcidin-25 selective antibodies and uses thereof |
06/08/2011 | EP2328930A1 Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe) |
06/08/2011 | EP2328929A2 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases |
06/08/2011 | EP2328928A2 Conserved influenza hemagglutinin epitope and antibodies thereto |
06/08/2011 | EP2328927A1 A method of binding bacterial lipopolysaccharides to a solid phase |
06/08/2011 | EP2328926A1 Treatment of thrombocytopenia |
06/08/2011 | EP2328917A1 Neuronal viability factor and use thereof |
06/08/2011 | EP2328914A1 Prevention, treatment and diagnosis of p.gingivalis infection |
06/08/2011 | EP2328909A1 Human catechol-o-methyltransferase (comt) assay |
06/08/2011 | EP2328616A1 Compositions and methods for antibodies targeting complement protein c5 |
06/08/2011 | EP2328559A2 Novel antibody formulation |
06/08/2011 | EP1817584B1 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
06/08/2011 | EP1573022B1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
06/08/2011 | EP1485127B1 Administration of agents for the treatment of inflammation |
06/08/2011 | EP1276765B1 Single-chain fertility hormones with variable lh activity |
06/08/2011 | EP1276500B1 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
06/08/2011 | EP1069185B1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody |
06/08/2011 | EP0960936B1 Reconstituted human anti-hm1.24 antibody |
06/08/2011 | CN1893979B Remedy for angitis |
06/08/2011 | CN1852736B Immunoglobulin chimeric monomer-dimer hybrids |
06/08/2011 | CN102089659A Abeta-oligomer measurement method |
06/08/2011 | CN102089431A Functionalized polypeptides |
06/08/2011 | CN102089327A Anti-PirB antibodies |
06/08/2011 | CN102089326A Anti-IL-6/IL-6R antibodies and methods of use thereof |
06/08/2011 | CN102089325A Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same |
06/08/2011 | CN102089324A Compositions and methods for the therapy and diagnosis of influenza |
06/08/2011 | CN102089005A Staphylococcus aureus-specific antibody preparations |
06/08/2011 | CN102089004A Pharmaceutical composition for treatment and prevention of cancer |
06/08/2011 | CN102087279A Enzyme linked immunosorbent assay kit for combined diagnosis of gastrosis or evaluation of gastric cancer risks |
06/08/2011 | CN102086230A Enzyme-linked immunosorbent assay kit for detecting melamine and application thereof |
06/08/2011 | CN102086229A Method for detecting melamine and enzyme-linked immunosorbent assay kit special for same |
06/08/2011 | CN102086228A ELISA (Enzyme Linked Immunosorbent Assay) Kit and application thereof |
06/08/2011 | CN101570577B Monoclonal antibody for O, O-dimethoxythiophosphate pesticides |
06/08/2011 | CN101381410B Rhodamine 123 artificial antigen synthesis, antibody preparation method and application |
06/08/2011 | CN101352571B Medicament for treating encephalitis b and preparation method thereof |
06/07/2011 | US7956173 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate |
06/07/2011 | US7956164 Device for enhancing immunostimulatory capabilities of T-cells |
06/07/2011 | US7956163 Antibodies that bind human OX2 receptors |
06/07/2011 | US7956160 Freeze dried protein composition comprising manitol polymorphs which reconstitute quickly upon addition of diluent and provide solutions of high protein concentrations, with reduced formation of foam, effervescence, bubbles, aggregates and particulates |
06/07/2011 | US7956038 GASP1: a follistatin domain containing protein |
06/07/2011 | US7955807 Method of measuring PTX3 with high sensitivity |
06/07/2011 | US7955600 Attenuated salmonella SP12 mutants as antigen carriers |
06/07/2011 | US7955598 Therapeutic agent for chronic arthritides diseases of childhood-related diseases |
06/07/2011 | US7955597 Anti-IL-6 antibodies, compositions, methods and uses |
06/07/2011 | CA2471144C Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
06/07/2011 | CA2441845C Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
06/07/2011 | CA2418422C Novel kallikrein gene |
06/07/2011 | CA2321226C Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
06/07/2011 | CA2232245C Cellulases, the genes encoding them and uses thereof |
06/07/2011 | CA2165949C Tuberculosis vaccine |
06/03/2011 | WO2011066503A2 Compositions and methods for the diagnosis and treatment of tumor |
06/03/2011 | WO2011066389A1 Targeted binding agents against b7-h1 |
06/03/2011 | WO2011065935A1 Methods for monoclonal antibody production |
06/03/2011 | WO2011064664A2 T cell receptors specific for immunodominant ctl epitopes of hcv |
06/03/2011 | WO2011064407A1 Agents for treating disease |
06/03/2011 | WO2011064399A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle) |
06/03/2011 | WO2011064398A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle) |
06/03/2011 | WO2011064395A2 Inhibitors and antagonists of calcium channels in the treatment of asthma |
06/03/2011 | WO2011064382A1 Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections |
06/03/2011 | WO2011064257A2 Monospecific polypeptide reagents |
06/03/2011 | WO2011064179A1 Marker protein for type 2 diabetes |
06/03/2011 | WO2011063980A1 Anti-c5a binding moieties with high blocking activity |
06/03/2011 | WO2011063523A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
06/03/2011 | WO2011022438A3 Cleavage sensitive antibodies and methods of use thereof |
06/03/2011 | WO2011011453A3 Phenotyping tumor-infiltrating leukocytes |
06/03/2011 | CA2782016A1 Monospecific polypeptide reagents |
06/03/2011 | CA2782007A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle) |
06/03/2011 | CA2782004A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle) |
06/03/2011 | CA2781887A1 Compositions and methods for the diagnosis and treatment of tumor |
06/03/2011 | CA2781836A1 Agents for treating disease |
06/03/2011 | CA2780520A1 Anti-c5a binding moieties with high blocking activity |